| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 57 | 2023 | 267 | 25.410 |
Why?
|
| Coronary Artery Disease | 27 | 2023 | 350 | 12.310 |
Why?
|
| Coronary Artery Bypass | 41 | 2023 | 228 | 11.930 |
Why?
|
| Endoscopy | 36 | 2023 | 332 | 11.300 |
Why?
|
| Cardiac Surgical Procedures | 20 | 2023 | 462 | 8.590 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 14 | 2022 | 35 | 7.980 |
Why?
|
| Robotics | 14 | 2022 | 267 | 5.350 |
Why?
|
| Mammary Arteries | 11 | 2023 | 31 | 4.900 |
Why?
|
| Coronary Vessels | 8 | 2023 | 177 | 3.890 |
Why?
|
| Minimally Invasive Surgical Procedures | 20 | 2023 | 237 | 3.710 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2023 | 166 | 3.450 |
Why?
|
| Percutaneous Coronary Intervention | 5 | 2020 | 58 | 3.330 |
Why?
|
| Treatment Outcome | 38 | 2023 | 7993 | 2.530 |
Why?
|
| Mitral Valve Insufficiency | 7 | 2022 | 187 | 2.450 |
Why?
|
| Aortic Valve | 8 | 2023 | 222 | 2.380 |
Why?
|
| Retrospective Studies | 31 | 2023 | 8489 | 1.910 |
Why?
|
| Vascular Patency | 9 | 2023 | 126 | 1.850 |
Why?
|
| Anastomosis, Surgical | 7 | 2021 | 267 | 1.740 |
Why?
|
| Humans | 97 | 2023 | 86643 | 1.740 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 131 | 1.740 |
Why?
|
| Mitral Valve | 10 | 2023 | 248 | 1.550 |
Why?
|
| Atrial Fibrillation | 5 | 2023 | 288 | 1.540 |
Why?
|
| Aorta | 3 | 2023 | 280 | 1.480 |
Why?
|
| Heart Neoplasms | 3 | 2019 | 62 | 1.480 |
Why?
|
| Coronary Angiography | 9 | 2023 | 232 | 1.440 |
Why?
|
| Aged | 37 | 2022 | 18415 | 1.420 |
Why?
|
| Middle Aged | 40 | 2023 | 25028 | 1.320 |
Why?
|
| Male | 48 | 2023 | 40965 | 1.210 |
Why?
|
| Pericardiectomy | 4 | 2020 | 9 | 1.200 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2023 | 42 | 1.070 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 225 | 1.030 |
Why?
|
| Length of Stay | 10 | 2020 | 702 | 1.010 |
Why?
|
| Carbapenems | 2 | 2016 | 9 | 1.000 |
Why?
|
| Myocardial Revascularization | 3 | 2021 | 31 | 1.000 |
Why?
|
| beta-Lactam Resistance | 2 | 2016 | 11 | 1.000 |
Why?
|
| Acinetobacter Infections | 2 | 2016 | 17 | 1.000 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 376 | 0.990 |
Why?
|
| Female | 40 | 2023 | 44532 | 0.980 |
Why?
|
| Thoracic Surgery | 2 | 2021 | 43 | 0.960 |
Why?
|
| Balloon Occlusion | 1 | 2023 | 27 | 0.910 |
Why?
|
| Fibroma | 2 | 2019 | 33 | 0.850 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 72 | 0.840 |
Why?
|
| Reoperation | 3 | 2019 | 597 | 0.820 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 181 | 0.820 |
Why?
|
| One-Lung Ventilation | 2 | 2020 | 4 | 0.810 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 109 | 0.810 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 6509 | 0.800 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 3 | 0.760 |
Why?
|
| Cross Infection | 2 | 2012 | 141 | 0.760 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 746 | 0.750 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 59 | 0.740 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2020 | 67 | 0.730 |
Why?
|
| Mortality | 2 | 2018 | 149 | 0.720 |
Why?
|
| Analgesia | 2 | 2021 | 57 | 0.720 |
Why?
|
| Pericarditis | 1 | 2019 | 13 | 0.710 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 295 | 0.700 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.700 |
Why?
|
| Physician Assistants | 1 | 2019 | 19 | 0.700 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 37 | 0.690 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 95 | 0.680 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 112 | 0.670 |
Why?
|
| Operative Time | 4 | 2019 | 127 | 0.660 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 111 | 0.660 |
Why?
|
| Tertiary Care Centers | 3 | 2016 | 94 | 0.650 |
Why?
|
| Blood Transfusion | 1 | 2019 | 157 | 0.650 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 99 | 0.640 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 130 | 0.630 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 218 | 0.600 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.600 |
Why?
|
| Suture Techniques | 1 | 2018 | 135 | 0.600 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2020 | 148 | 0.580 |
Why?
|
| Stroke | 2 | 2023 | 965 | 0.570 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 26 | 0.570 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2018 | 228 | 0.560 |
Why?
|
| Heart Ventricles | 2 | 2019 | 760 | 0.560 |
Why?
|
| Postoperative Complications | 5 | 2018 | 2207 | 0.560 |
Why?
|
| Equipment Design | 5 | 2018 | 406 | 0.560 |
Why?
|
| beta-Lactamases | 1 | 2016 | 52 | 0.550 |
Why?
|
| Hemorrhage | 1 | 2018 | 268 | 0.550 |
Why?
|
| Catheter Ablation | 2 | 2016 | 233 | 0.540 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2022 | 47 | 0.540 |
Why?
|
| Bupivacaine | 1 | 2015 | 45 | 0.540 |
Why?
|
| Laparoscopy | 1 | 2022 | 754 | 0.520 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 76 | 0.520 |
Why?
|
| Heart Diseases | 1 | 2017 | 290 | 0.520 |
Why?
|
| Adult | 14 | 2023 | 25648 | 0.510 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 3640 | 0.500 |
Why?
|
| Pain Management | 1 | 2015 | 127 | 0.490 |
Why?
|
| Risk Factors | 8 | 2021 | 5417 | 0.460 |
Why?
|
| Heart Arrest, Induced | 2 | 2022 | 31 | 0.440 |
Why?
|
| Acinetobacter | 1 | 2012 | 4 | 0.430 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 25 | 0.410 |
Why?
|
| Klebsiella pneumoniae | 1 | 2012 | 34 | 0.410 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 154 | 0.390 |
Why?
|
| Heart | 3 | 2023 | 539 | 0.370 |
Why?
|
| Coronary Disease | 1 | 2011 | 261 | 0.370 |
Why?
|
| Heart Valve Prosthesis | 2 | 2022 | 93 | 0.370 |
Why?
|
| Saudi Arabia | 3 | 2016 | 16 | 0.360 |
Why?
|
| Tricuspid Valve | 2 | 2020 | 96 | 0.350 |
Why?
|
| Postoperative Period | 3 | 2019 | 303 | 0.350 |
Why?
|
| Perioperative Period | 2 | 2019 | 25 | 0.340 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2020 | 68 | 0.340 |
Why?
|
| Heart Atria | 2 | 2016 | 250 | 0.330 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 131 | 0.330 |
Why?
|
| Heart Failure | 1 | 2018 | 1204 | 0.320 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 344 | 0.320 |
Why?
|
| Pericardium | 2 | 2019 | 65 | 0.310 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2018 | 62 | 0.310 |
Why?
|
| Prosthesis Design | 2 | 2019 | 278 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 187 | 0.310 |
Why?
|
| Stroke Volume | 2 | 2022 | 456 | 0.300 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 663 | 0.290 |
Why?
|
| Feasibility Studies | 2 | 2019 | 751 | 0.290 |
Why?
|
| Echocardiography, Three-Dimensional | 3 | 2017 | 516 | 0.290 |
Why?
|
| Surgeons | 2 | 2021 | 238 | 0.280 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 592 | 0.280 |
Why?
|
| Hemodynamics | 2 | 2020 | 710 | 0.280 |
Why?
|
| Heart Transplantation | 2 | 2023 | 705 | 0.260 |
Why?
|
| Chordae Tendineae | 2 | 2015 | 23 | 0.260 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 1686 | 0.250 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2019 | 99 | 0.250 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 413 | 0.250 |
Why?
|
| Endoscopes | 1 | 2004 | 9 | 0.240 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 143 | 0.240 |
Why?
|
| Surgical Stapling | 1 | 2004 | 17 | 0.240 |
Why?
|
| Microwaves | 1 | 2004 | 34 | 0.240 |
Why?
|
| Sternotomy | 1 | 2023 | 20 | 0.240 |
Why?
|
| Hospital Mortality | 2 | 2019 | 349 | 0.240 |
Why?
|
| Constriction | 1 | 2023 | 27 | 0.230 |
Why?
|
| Cluster Analysis | 2 | 2016 | 369 | 0.230 |
Why?
|
| Internship and Residency | 2 | 2023 | 1004 | 0.220 |
Why?
|
| Patient Positioning | 2 | 2020 | 63 | 0.220 |
Why?
|
| Sternum | 1 | 2022 | 30 | 0.220 |
Why?
|
| Thoracotomy | 1 | 2022 | 58 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 827 | 0.210 |
Why?
|
| Time Factors | 3 | 2019 | 5210 | 0.200 |
Why?
|
| Prognosis | 2 | 2019 | 3679 | 0.200 |
Why?
|
| Colombia | 1 | 2020 | 11 | 0.200 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 50 | 0.190 |
Why?
|
| Survival Analysis | 2 | 2017 | 1538 | 0.190 |
Why?
|
| Morphine | 1 | 2021 | 130 | 0.190 |
Why?
|
| Myocardial Bridging | 1 | 2020 | 3 | 0.190 |
Why?
|
| Lead Poisoning | 1 | 2020 | 10 | 0.190 |
Why?
|
| Nobel Prize | 1 | 2020 | 10 | 0.190 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 22 | 0.190 |
Why?
|
| Patient Discharge | 1 | 2023 | 300 | 0.180 |
Why?
|
| Prevalence | 3 | 2023 | 1239 | 0.180 |
Why?
|
| Simulation Training | 1 | 2021 | 88 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 63 | 0.180 |
Why?
|
| Career Choice | 1 | 2021 | 139 | 0.180 |
Why?
|
| Epicardial Mapping | 1 | 2019 | 10 | 0.180 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2019 | 19 | 0.180 |
Why?
|
| Multidetector Computed Tomography | 1 | 2020 | 54 | 0.180 |
Why?
|
| Pain | 1 | 2022 | 391 | 0.180 |
Why?
|
| Young Adult | 3 | 2017 | 5976 | 0.170 |
Why?
|
| Inservice Training | 1 | 2019 | 38 | 0.170 |
Why?
|
| History, 21st Century | 1 | 2020 | 175 | 0.170 |
Why?
|
| Genotype | 2 | 2016 | 1851 | 0.170 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 7 | 0.170 |
Why?
|
| Bioprosthesis | 1 | 2019 | 36 | 0.170 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 139 | 0.170 |
Why?
|
| Safety | 1 | 2019 | 152 | 0.170 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2019 | 66 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2020 | 312 | 0.170 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.170 |
Why?
|
| Vascular Calcification | 1 | 2019 | 39 | 0.160 |
Why?
|
| Medicare | 1 | 2022 | 410 | 0.160 |
Why?
|
| Interactive Ventilatory Support | 1 | 2018 | 5 | 0.160 |
Why?
|
| Surgical Staplers | 1 | 2018 | 11 | 0.160 |
Why?
|
| Recovery of Function | 1 | 2019 | 272 | 0.160 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 129 | 0.160 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2017 | 16 | 0.160 |
Why?
|
| Radial Artery | 1 | 2017 | 33 | 0.150 |
Why?
|
| Gender Identity | 1 | 2018 | 52 | 0.150 |
Why?
|
| Saphenous Vein | 1 | 2017 | 61 | 0.150 |
Why?
|
| Morbidity | 1 | 2018 | 148 | 0.150 |
Why?
|
| Child, Preschool | 2 | 2016 | 3612 | 0.150 |
Why?
|
| Acute Disease | 1 | 2019 | 826 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 114 | 0.150 |
Why?
|
| Echocardiography | 2 | 2019 | 911 | 0.150 |
Why?
|
| Risk | 1 | 2018 | 674 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2017 | 78 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 240 | 0.150 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1801 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2018 | 4213 | 0.150 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 11 | 0.150 |
Why?
|
| Overweight | 1 | 2017 | 118 | 0.140 |
Why?
|
| Atrial Septum | 1 | 2016 | 9 | 0.140 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 53 | 0.140 |
Why?
|
| Pericarditis, Constrictive | 1 | 2016 | 5 | 0.140 |
Why?
|
| Recurrence | 1 | 2019 | 1139 | 0.140 |
Why?
|
| Coronary Sinus | 1 | 2016 | 7 | 0.140 |
Why?
|
| Ventricular Fibrillation | 1 | 2016 | 65 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2020 | 428 | 0.140 |
Why?
|
| Heart Conduction System | 1 | 2016 | 108 | 0.140 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 87 | 0.140 |
Why?
|
| Plasmids | 1 | 2016 | 287 | 0.140 |
Why?
|
| Liposomes | 1 | 2015 | 91 | 0.130 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 236 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 31 | 0.130 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 17 | 0.130 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 115 | 0.130 |
Why?
|
| Organ Preservation Solutions | 1 | 1995 | 28 | 0.130 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 87 | 0.130 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 64 | 0.130 |
Why?
|
| Therapeutics | 1 | 2014 | 12 | 0.130 |
Why?
|
| Organ Preservation | 1 | 1995 | 83 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2601 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 110 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 351 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2018 | 770 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 185 | 0.120 |
Why?
|
| Device Removal | 1 | 2016 | 161 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 927 | 0.120 |
Why?
|
| Comorbidity | 1 | 2017 | 943 | 0.120 |
Why?
|
| Quality of Life | 1 | 2021 | 1585 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 1995 | 306 | 0.110 |
Why?
|
| Ischemia | 1 | 1995 | 243 | 0.110 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 39 | 0.110 |
Why?
|
| Child | 2 | 2016 | 6927 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1805 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 853 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2016 | 265 | 0.110 |
Why?
|
| Software | 1 | 2017 | 654 | 0.110 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 20 | 0.110 |
Why?
|
| Molecular Typing | 1 | 2012 | 17 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 44 | 0.100 |
Why?
|
| Wisconsin | 1 | 2011 | 39 | 0.100 |
Why?
|
| Adolescent | 2 | 2016 | 8981 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 731 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2012 | 2767 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 99 | 0.100 |
Why?
|
| Electrocardiography | 3 | 2019 | 478 | 0.100 |
Why?
|
| Obesity | 1 | 2017 | 963 | 0.100 |
Why?
|
| Hypertension | 1 | 2019 | 1141 | 0.100 |
Why?
|
| Infection Control | 1 | 2012 | 115 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2705 | 0.090 |
Why?
|
| Algorithms | 2 | 2017 | 1830 | 0.090 |
Why?
|
| Burns | 1 | 2012 | 131 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2012 | 678 | 0.090 |
Why?
|
| Survival Rate | 2 | 2011 | 1863 | 0.090 |
Why?
|
| Lung | 1 | 1995 | 1170 | 0.080 |
Why?
|
| Angiography | 1 | 2009 | 208 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2012 | 373 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2009 | 162 | 0.080 |
Why?
|
| Image Enhancement | 3 | 2017 | 563 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2021 | 2261 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 1991 | 0.070 |
Why?
|
| Hospitalization | 1 | 2012 | 849 | 0.070 |
Why?
|
| Infant | 1 | 2012 | 3046 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2021 | 751 | 0.070 |
Why?
|
| Disease Progression | 1 | 2009 | 1531 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 90 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 121 | 0.060 |
Why?
|
| Demography | 1 | 2023 | 177 | 0.060 |
Why?
|
| Risk Adjustment | 1 | 2022 | 39 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2021 | 44 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 244 | 0.050 |
Why?
|
| Decontamination | 1 | 2021 | 9 | 0.050 |
Why?
|
| Weights and Measures | 1 | 2020 | 7 | 0.050 |
Why?
|
| Contraindications | 1 | 2020 | 72 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2023 | 463 | 0.050 |
Why?
|
| Perception | 1 | 2021 | 168 | 0.050 |
Why?
|
| United States | 2 | 2023 | 6672 | 0.050 |
Why?
|
| Myocardium | 1 | 2022 | 529 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 294 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 369 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 335 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 171 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 6 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 539 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1823 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1054 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 148 | 0.040 |
Why?
|
| Heart Injuries | 1 | 2016 | 16 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 685 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 579 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1996 | 143 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1996 | 127 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 184 | 0.030 |
Why?
|
| Thromboxane B2 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Raffinose | 1 | 1995 | 24 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 971 | 0.030 |
Why?
|
| Partial Pressure | 1 | 1995 | 50 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 59 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1995 | 102 | 0.030 |
Why?
|
| Reperfusion | 1 | 1995 | 31 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.030 |
Why?
|
| Glutathione | 1 | 1995 | 104 | 0.030 |
Why?
|
| Allopurinol | 1 | 1995 | 80 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 103 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 108 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 329 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 455 | 0.030 |
Why?
|
| Rabbits | 1 | 1995 | 636 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 602 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 865 | 0.030 |
Why?
|
| Adenosine | 1 | 1995 | 225 | 0.030 |
Why?
|
| Radiography | 1 | 2013 | 813 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 397 | 0.020 |
Why?
|
| Oxygen | 1 | 1995 | 726 | 0.020 |
Why?
|
| Insulin | 1 | 1995 | 1160 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1995 | 1143 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 80 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 1996 | 112 | 0.010 |
Why?
|
| Animals | 1 | 1995 | 26582 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1996 | 999 | 0.010 |
Why?
|